Literature DB >> 24692577

Biologic therapy for rheumatoid arthritis in developing countries--a place for non-TNF inhibitors as first-line treatment?

Mohammed Tikly1, Bridget Hodkinson2, Keertan Dheda3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24692577     DOI： 10.1093/rheumatology/keu040

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  2 in total

1.  Rheumatoid arthritis in the Middle East and Africa: are we any closer to optimising its management?

Authors:  Jamal Al Saleh; Gaafar Ragab; Peter Nash; Hussein Halabi; Ahmed Laatar; Ali M El-Sayed Yousef; Hamdi Ehsouna; Mohammed Hammoudeh
Journal:  Clin Rheumatol       Date:  2014-11-07       Impact factor: 2.980

2.  Incident tuberculosis disease in patients receiving biologic therapies in the Western Cape, South Africa from 2007 to 2018.

Authors:  Tessa du Toit; Tonya M Esterhuizen; Nicki Tiffin; Ahmed A Abulfathi; Helmuth Reuter; Eric H Decloedt
Journal:  BMC Infect Dis       Date:  2020-11-30       Impact factor: 3.090
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.